SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 147 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $668,796 | -70.3% | 1,866,186 | -44.5% | 0.00% | – |
Q1 2024 | $2,254,668 | +29.4% | 3,363,791 | +4.9% | 0.00% | – |
Q4 2023 | $1,742,178 | -3.1% | 3,206,310 | +7.0% | 0.00% | – |
Q3 2023 | $1,798,387 | -51.6% | 2,997,926 | +5.0% | 0.00% | – |
Q2 2023 | $3,712,477 | -18.5% | 2,855,752 | +10.3% | 0.00% | -100.0% |
Q1 2023 | $4,557,222 | +58079.8% | 2,589,331 | +3.8% | 0.00% | 0.0% |
Q4 2022 | $7,833 | -99.9% | 2,494,871 | +4.7% | 0.00% | -50.0% |
Q3 2022 | $11,673,000 | +30.0% | 2,382,435 | +9.8% | 0.00% | +100.0% |
Q2 2022 | $8,979,000 | -26.1% | 2,169,013 | +3.7% | 0.00% | -50.0% |
Q1 2022 | $12,156,000 | -27.3% | 2,092,371 | -6.1% | 0.00% | 0.0% |
Q4 2021 | $16,718,000 | -15.5% | 2,229,183 | +1.5% | 0.00% | -33.3% |
Q3 2021 | $19,780,000 | -19.8% | 2,195,343 | +6.5% | 0.00% | 0.0% |
Q2 2021 | $24,664,000 | -0.6% | 2,060,536 | +4.1% | 0.00% | -25.0% |
Q1 2021 | $24,808,000 | -12.4% | 1,979,960 | +9.1% | 0.00% | -20.0% |
Q4 2020 | $28,319,000 | +70.4% | 1,814,837 | +3.2% | 0.01% | +66.7% |
Q3 2020 | $16,620,000 | +4.7% | 1,758,834 | -0.8% | 0.00% | 0.0% |
Q2 2020 | $15,881,000 | +47.6% | 1,772,502 | +4.9% | 0.00% | 0.0% |
Q1 2020 | $10,759,000 | -59.4% | 1,689,025 | -46.7% | 0.00% | 0.0% |
Q4 2019 | $26,524,000 | +91.2% | 3,169,138 | +106.7% | 0.00% | 0.0% |
Q3 2019 | $13,873,000 | -13.3% | 1,532,968 | +3.2% | 0.00% | -25.0% |
Q2 2019 | $16,005,000 | +34.0% | 1,486,150 | +18.7% | 0.00% | +33.3% |
Q1 2019 | $11,948,000 | -53.9% | 1,252,473 | -44.5% | 0.00% | -25.0% |
Q4 2018 | $25,930,000 | +37.4% | 2,258,730 | +102.8% | 0.00% | -20.0% |
Q3 2018 | $18,875,000 | +22.9% | 1,113,615 | +3.0% | 0.01% | 0.0% |
Q2 2018 | $15,357,000 | -3.5% | 1,081,568 | +29.1% | 0.01% | 0.0% |
Q1 2018 | $15,921,000 | +15.6% | 837,995 | -0.3% | 0.01% | 0.0% |
Q4 2017 | $13,777,000 | +11.9% | 840,104 | +2.3% | 0.01% | 0.0% |
Q3 2017 | $12,315,000 | +92.3% | 821,017 | +12.8% | 0.01% | +66.7% |
Q2 2017 | $6,403,000 | +94.3% | 727,615 | +14.8% | 0.00% | +200.0% |
Q1 2017 | $3,296,000 | +75.9% | 633,964 | +3.1% | 0.00% | 0.0% |
Q4 2016 | $1,874,000 | -21.0% | 614,633 | +19.9% | 0.00% | 0.0% |
Q3 2016 | $2,373,000 | -18.1% | 512,638 | +2.5% | 0.00% | -50.0% |
Q2 2016 | $2,896,000 | -1.3% | 500,351 | +3.2% | 0.00% | 0.0% |
Q1 2016 | $2,933,000 | -29.9% | 484,858 | +5.7% | 0.00% | 0.0% |
Q4 2015 | $4,186,000 | +71.6% | 458,557 | +6.0% | 0.00% | +100.0% |
Q3 2015 | $2,440,000 | -48.9% | 432,670 | +0.5% | 0.00% | -66.7% |
Q2 2015 | $4,776,000 | -25.9% | 430,676 | +4.8% | 0.00% | -25.0% |
Q1 2015 | $6,445,000 | +4.0% | 411,127 | +0.9% | 0.00% | 0.0% |
Q4 2014 | $6,196,000 | +29.0% | 407,400 | -8.5% | 0.00% | +33.3% |
Q3 2014 | $4,803,000 | -18.2% | 445,345 | +15.8% | 0.00% | -25.0% |
Q2 2014 | $5,871,000 | -11.4% | 384,501 | +5.0% | 0.00% | 0.0% |
Q1 2014 | $6,623,000 | +38.6% | 366,361 | +6.5% | 0.00% | +33.3% |
Q4 2013 | $4,777,000 | +73.7% | 343,988 | +31.1% | 0.00% | +50.0% |
Q3 2013 | $2,750,000 | +60.0% | 262,347 | +19.2% | 0.00% | 0.0% |
Q2 2013 | $1,719,000 | – | 220,076 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 968,505 | $12,135,000 | 1.23% |
Golden State Equity Partners | 126,608 | $1,586,000 | 0.90% |
McGuire Investment Group, LLC | 272,801 | $3,418,000 | 0.72% |
Lombard Odier Asset Management (Switzerland) SA | 848,429 | $10,631,000 | 0.70% |
Rhenman & Partners Asset Management AB | 765,000 | $9,585,000 | 0.67% |
EMC Capital Management | 72,061 | $903,000 | 0.64% |
WASATCH ADVISORS LP | 10,328,423 | $129,415,000 | 0.58% |
Ceeto Capital Group, LLC | 74,000 | $927,000 | 0.45% |
Fort Sheridan Advisors LLC | 75,945 | $952,000 | 0.38% |
Vanguard Capital Wealth Advisors | 34,580 | $388,679,000 | 0.33% |